Subscribe to RSS

DOI: 10.4103/ijmbs.ijmbs_5_21
Family history in patients with end-stage renal disease on hemodialysis in Tripoli, Libya


Background: End-Stage Renal Disease (ESRD) is a global health problem due to increasing its burden worldwide. High-risk groups include family members of patients with ESRD. Objectives: To determine the prevalence of ESRD among dialysis patients' families. At Al-Shat kidney dialysis Center, Tripoli, Libya. So can conclude that the ESRD patient is an index case for a high- risk population. Methods: All patients' data were collected through direct interview with the patients for 15- 20 minutes and by reviewing patients' charts. Patients who decline consent to participate and those with mental or speech disability were excluded, and patients on peritoneal dialysis. The study carried at Al-Shat kidney dialysis centre, Tripoli, Libya. In January 2019. Results: 261 patients were interviewed, mean age 51.8 years (±15), nearly half (48.7%) of them, between 45 to 65 years and 31.8% younger than 45 years. 56.3% were men, and 43.7% were women. The leading causes of ESRD in these patients were DM, HTN, congenital abnormalities (APCKD/VUR) and GN (35.2%, 22.2%, 10%, 8%). Positive family history of ESRD was reportedby 26.8% of these patients. From them, 47% (33/70) were between 45 to 65 years ofage. 58.6% were male (41/70). 34.3% have diabetic, 20% have HTN, 13%have congenital abnormalities, and 7% GN. Conclusions: Positive familyhistory of ESRD was high in dialysis patients. These patients can be used as anindex case to identify high- risk population.
Key-words:
ESRD End-Stage Renal Disease - DM Diabetes Millets - HTN Hypertension - APCKD AdultPolycystic Kidney Disease. VUR Vasico-Ureteric Reflux.Financial support and sponsorship
Nil.
Publication History
Received: 10 January 2021
Accepted: 24 March 2021
Article published online:
14 July 2022
© 2021. The Libyan Authority of Scientific Research and Technologyand the Libyan Biotechnology Research Center. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License,permitting copying and reproductionso long as the original work is given appropriate credit. Contents may not be used for commercial purposes, oradapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India